Valuation: Sandoz Group AG

Market Cap 36.72B 32.81B 30.61B 27.8B 52.36B 3,552B 52.75B 368B 144B 1,806B 138B 135B 5,807B P/E 2026 *
31.8x
P/E 2027 * 22.9x
Enterprise Value 40.46B 36.15B 33.72B 30.63B 57.69B 3,913B 58.12B 405B 158B 1,990B 152B 149B 6,398B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.13x
Free-Float
94.15%
Yield 2026 *
1.27%
Yield 2027 * 1.58%
1 day-1.99%
1 week+2.07%
Current month-3.27%
1 month+3.50%
6 months+9.63%
Current year+21.31%
1 week 71.5
Extreme 71.5
75.5
1 month 68.5
Extreme 68.5
78
Current year 60.5
Extreme 60.5
79.5
1 year 51
Extreme 51
79.5
3 years 24.2
Extreme 24.2
79.5
5 years 24.2
Extreme 24.2
79.5
10 years 24.2
Extreme 24.2
79.5
Manager TitleAgeSince
Chief Executive Officer 59 2018-12-31
Director of Finance/CFO 58 2024-06-30
Chief Tech/Sci/R&D Officer 59 2025-05-31
Director TitleAgeSince
Director/Board Member 63 2023-07-31
Chairman 66 2023-02-28
Director/Board Member 61 2023-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%+2.07% - - 36.72B
+2.70%+2.73%+40.91%+110.31% 1,060B
+1.44%-2.38%+36.83%+63.95% 623B
+1.75%+3.73%+16.55%+83.05% 480B
+0.60%-1.73%+62.98%+37.46% 352B
-1.15%+1.75%+21.90%+41.56% 345B
-0.97%+0.51%+11.42%+34.64% 274B
-0.89%-1.82%-5.67%+11.05% 249B
+2.60%-2.00%+39.77%+54.44% 223B
+1.82%-1.48%+25.75%+96.48% 182B
Average -0.42%-0.48%+27.83%+59.22% 420.89B
Weighted average by Cap. -0.23%+0.04%+31.48%+70.23%

Financials

2026 *2027 *
Net sales 12.1B 10.81B 10.09B 9.16B 17.26B 1,171B 17.39B 121B 47.36B 595B 45.43B 44.45B 1,914B 12.74B 11.39B 10.62B 9.65B 18.17B 1,233B 18.31B 128B 49.87B 627B 47.84B 46.81B 2,015B
Net income 1.13B 1.01B 941M 855M 1.61B 109B 1.62B 11.31B 4.42B 55.54B 4.24B 4.15B 179B 1.66B 1.48B 1.38B 1.25B 2.36B 160B 2.38B 16.6B 6.49B 81.53B 6.22B 6.09B 262B
Net Debt 3.74B 3.34B 3.12B 2.83B 5.33B 362B 5.37B 37.44B 14.63B 184B 14.03B 13.73B 591B 3.22B 2.88B 2.68B 2.44B 4.59B 312B 4.63B 32.26B 12.6B 158B 12.09B 11.83B 509B
Projected Income Statement - Annual - Sandoz Group AG
Logo Sandoz Group AG
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Employees
20,000
Date Price Change Volume
26-10-08 €74.00 -1.99% 0
26-10-07 €75.50 +2.72% 20
26-10-06 €73.50 +2.80% 0
26-10-05 €71.50 -1.38% 0
26-10-02 €72.50 0.00% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Sandoz Group AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
84.86USD
Average target price
91.80USD
Spread / Average Target
+8.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sandoz Group AG